- Home
- BCRX vs CLOV Comparison
BCRX vs CLOV Comparison
Compare BCRX & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CLOV
- Stock Information
- Founded
- BCRX 1986
- CLOV 2014
- Country
- BCRX United States
- CLOV United States
- Employees
- BCRX N/A
- CLOV N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CLOV Medical Specialities
- Sector
- BCRX Health Care
- CLOV Health Care
- Exchange
- BCRX Nasdaq
- CLOV Nasdaq
- Market Cap
- BCRX 1.7B
- CLOV 1.9B
- IPO Year
- BCRX 1994
- CLOV N/A
- Fundamental
- Price
- BCRX $9.92
- CLOV $3.85
- Analyst Decision
- BCRX Buy
- CLOV Strong Buy
- Analyst Count
- BCRX 8
- CLOV 3
- Target Price
- BCRX $16.75
- CLOV $4.83
- AVG Volume (30 Days)
- BCRX 5.7M
- CLOV 5.1M
- Earning Date
- BCRX 05-05-2025
- CLOV 05-06-2025
- Dividend Yield
- BCRX N/A
- CLOV N/A
- EPS Growth
- BCRX N/A
- CLOV N/A
- EPS
- BCRX N/A
- CLOV N/A
- Revenue
- BCRX $503,485,000.00
- CLOV $1,486,073,000.00
- Revenue This Year
- BCRX $27.64
- CLOV $47.67
- Revenue Next Year
- BCRX $13.42
- CLOV $13.64
- P/E Ratio
- BCRX N/A
- CLOV N/A
- Revenue Growth
- BCRX 41.67
- CLOV N/A
- 52 Week Low
- BCRX $5.06
- CLOV $0.79
- 52 Week High
- BCRX $11.11
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- BCRX 65.51
- CLOV 57.99
- Support Level
- BCRX $8.28
- CLOV $3.26
- Resistance Level
- BCRX $11.11
- CLOV $3.90
- Average True Range (ATR)
- BCRX 0.51
- CLOV 0.15
- MACD
- BCRX 0.25
- CLOV 0.04
- Stochastic Oscillator
- BCRX 69.17
- CLOV 71.97
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.